(PharmaNewsWire.Com, February 09, 2017 ) According to Publisher, ENT devices market is expected to grow from $9,100 million in 2015 to $14,785 million by 2022 at a CAGR of 7.2%. The major factors impacting ENT device market growth are increasing aging population and related disorders such as lower functioning levels of ear, nose, & throat and hearing loss. In addition, technological advancements, rising occurrence of chronic sinusitis, increasing adoption of minimally invasive ENT procedures and increasing disposable income levels are fueling the growth of global ENT devices market. However limited battery life, stringent reimbursement policy, lack of skilled professionals and high costs of ENT devices are the factors hampering the market growth.
By product, hearing implants segment is expected to witness high growth rate during the forecast period. Hearing aids segment is likely to acquire the largest market share on account of rapidly increasing advanced and user friendly devices. North America is anticipated to be the largest market while, Asia Pacific is projected to grow at a faster pace. The growth of this region is attributed to rising levels of disposable income, presence of target disease people and increasing demand for ENT devices from the emerging regions such as China, Japan and India.
Some of the key players in global ENT device market include Acclarent Inc., American Hearing Systems Inc., Audiosync Inc., Beltone, Cochlear Ltd., GN ReSound A/S, Hoya Corporation, Karl Storz Gmbh & Co. Kg, Medtronic PLC, Olympus Corporation, Panasonic Corporation, Rexton Inc., Siemens Healthcare GmbH, Smith & Nephew PLC, Sonic Innovations Inc., Sonova Holding AG, Starkey Laboratories Inc., Unitron Hearing Inc., William Demant Holding A/S, and Zounds Inc.
Products Covered: -Diagnostic Devices -Hearing Screening Devices -Endoscopes -Surgical Devices -Radiofrequency (RF) Handpieces -Powered Surgical Instruments -Handheld Instruments -Balloon Sinus Dilation Devices -ENT Supplies -Voice Prosthesis Devices -Ear Tubes -Co2 Lasers -Image-Guided Surgery Systems -Hearing Aids -Canal hearing aids ITC, CIC and IIC -In-the-Ear aids -Behind-the-Ear (BTE) aids -Receiver-in-the-Ear (RITE) -Hearing Implants -Middle Ear Implants -Bone Anchored Hearing System -Cochlear Implants -Auditory Brainstem Implants End Users Covered: -ENT Clinics -Ambulatory Settings -Home Use -Hospitals Regions Covered: -North America -US -Canada
9 Company Profiling 9.1 Acclarent Inc. 9.2 American Hearing Systems Inc. 9.3 Audiosync Inc. 9.4 Beltone 9.5 Cochlear Ltd. 9.6 GN ReSound A/S 9.7 Hoya Corporation 9.8 Karl Storz Gmbh & Co. Kg 9.9 Medtronic PLC 9.10 Olympus Corporation 9.11 Panasonic Corporation 9.12 Rexton Inc. 9.13 Siemens Healthcare GmbH 9.14 Smith & Nephew PLC 9.15 Sonic Innovations Inc. 9.16 Sonova Holding AG 9.17 Starkey Laboratories Inc. 9.18 Unitron Hearing Inc. 9.19 William Demant Holding A/S 9.20 Zounds Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
